Topiramate Extended-Release

Trokendi

Strengths & Sizes

Topiramate Extended-Release
Topiramate Extended-Release

Note: product and packaging images are not actual size

  • NDC#31722-547-30
  • UPC Code331722547307
  • ImprintA / 539
Topiramate Extended-Release
Topiramate Extended-Release

Note: product and packaging images are not actual size

  • NDC#31722-548-30
  • UPC Code331722548304
  • ImprintA / 540
Topiramate Extended-Release
Topiramate Extended-Release

Note: product and packaging images are not actual size

  • NDC#31722-549-30
  • UPC Code331722549301
  • ImprintA / 541
Topiramate Extended-Release
Topiramate Extended-Release

Note: product and packaging images are not actual size

  • NDC#31722-550-30
  • UPC Code331722550307
  • ImprintA / 542

Indications

Topiramate extended-release capsules are indicated for: Epilepsy: initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 6 years of age and older; adjunctive therapy for the treatment of partial-onset, primary generalized tonicclonic seizures, or seizures associated with Lennox-Gastaut syndrome (LGS) in patients 6 years of age and older; Preventive treatment of migraine in patients 12 years of age and older (1.3)